Details of the Drug

General Information of Drug (ID: DMAJ0B4)

Drug Name
1,2,3,7,12,12a-hexahydro-1-aza-pleiadene-5,6-diol
Synonyms CHEMBL253948; 1,2,3,7,12,12a-hexahydro-1-aza-pleiadene-5,6-diol
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 267.32
Logarithm of the Partition Coefficient (xlogp) 2.6
Rotatable Bond Count (rotbonds) 0
Hydrogen Bond Donor Count (hbonddonor) 3
Hydrogen Bond Acceptor Count (hbondacc) 3
Chemical Identifiers
Formula
C17H17NO2
IUPAC Name
11-azatetracyclo[8.7.1.03,8.014,18]octadeca-1(18),3,5,7,14,16-hexaene-16,17-diol
Canonical SMILES
C1CNC2CC3=CC=CC=C3CC4=C2C1=CC(=C4O)O
InChI
InChI=1S/C17H17NO2/c19-15-9-12-5-6-18-14-8-11-4-2-1-3-10(11)7-13(16(12)14)17(15)20/h1-4,9,14,18-20H,5-8H2
InChIKey
SVRDMCXMTWERHI-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
44448066
TTD ID
D0A4GE

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Dopamine D1 receptor (D1R) TTZFYLI DRD1_HUMAN Inhibitor [1]
Dopamine D2 receptor (D2R) TTEX248 DRD2_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease Discovery agent
ICD Disease Classification N.A.
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Dopamine D1 receptor (D1R) DTT DRD1 8.99E-01 -0.06 -0.3
Dopamine D2 receptor (D2R) DTT DRD2 2.20E-03 -0.51 -1.35
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 Advances in development of dopaminergic aporphinoids. J Med Chem. 2007 Jan 25;50(2):171-81.